MAP1LC3A and neoplasm: Administration of two high dose doxorubicin (10 mg/kg) treatments over 3 days in GFP-LC3 mice bearing large E0771 tumors (>230 mm2) resulted in significant reductions in tumor size by day eight after the first intervention (Figure 10B).